Overview of Drug Discovery & Development
Drug discovery and development together are the complete process that is intended to identify a new drug for comprehensive evaluation and bring it to market. Broadly, discovery may involve selection of a druggable molecular target and high throughput screening of compound libraries against the target to identify hits. Development includes studies on the biological target in vitro and in animal models of disease, clinical trials, and ultimately regulatory approval. Creative Biolabs is recognized as the world leader in providing flexible drug discovery & development solutions for worldwide customers. Our platform enables you to move your molecule through each early development phase with efficiency and speed.
Fig 1. Imaging applications in the drug discovery and development process (Markus, 2003)
The pharmaceutical industry is an important part of the global health care system. It is made up of many public and private organizations that discover, develop, manufacture and market human and animal health medicines. The modern pharmaceutical industry has come a long way from its roots in 19th century pharmacy. The roots lie back with local apothecaries that expanded from their traditional role in distributing botanical drugs. Pharmaceutical science improved markedly in the 19th and 20th centuries. At the end of the 20th century, the pharmaceutical industry has become a large enterprise and many countries are trying to develop the infrastructure necessary for drug companies to compete on a worldwide scale.
Categories of diseases include cancer, blood, bacterial, autoimmune, neurodegenerative, and transmitted. A disease is an abnormal condition affecting a living organism and involves a pathological process associated with a specific set of symptoms. Nowadays, a variety of therapies have been developed to meet the different disease needs. Creative Biolabs is committed to providing technical support and validation services to accelerate the development of gene therapy, immunotherapy, stem cell therapy, and virotherapy. We can provide customers with comprehensive project customization services.
Generally, a contract research organization (CRO) is a company that conducts clinical trials and research support services for pharmaceutical, biotechnology, and medical device industries. The earliest CRO companies like Huntingdon Life Sciences and Charles River Laboratories were founded in the 1940s and 1950s. Later, in the early 90s, the role of the CRO shifted and played a more long-term role during the drug discovery and development process. Today, many companies could provide a package service from preclinical and clinical testing to regulatory approval at the end of the process. Creative Biolabs as a leading CRO company can provide flexible and comprehensive solutions to support your project.
Drug discovery is a process that involves the identification of candidates, synthesis, screening, and assays for therapeutic efficacy. After the investigations, the significate compound will initiate the process of drug development to clinical trials. Drug development process needs several stages to make a medicine that is high-quality and approved of all regulatory requirements. As we all know, the drug discovery and development process are sufficiently long, complex, and expensive. It will take about 12-15 years and US $1 billion from discovery to the approved medicine.
Rudin, M. and Weissleder, R., 2003. Molecular imaging in drug discovery and development. Nature Reviews Drug Discovery, 2(2), pp.123-131.
For Research Use Only